Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study

Published:2021-07-20 Issue:8 Volume:35 Page:881-892
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Ludwig Vera M.^ORCID,Sauer Cathrin,Young Allan H.^ORCID,Rucker James^ORCID,Bauer Michael^ORCID,Findeis Hannelore,Ritter Philipp^ORCID

Funder

Bundesministerium für Bildung und Forschung

National Institute for Health Research

Deutsche Forschungsgemeinschaft

NIHR Biomedical Research Centre

European Commission

Novartis Pharma

Aristo

Hexal AG

Janssen Pharmaceuticals

Janssen-Cilag

Sunovion

GH Research

neuraxpharm

Sandoz

Shire International GmbH

Dainippon Sumitomo Pharma

Takeda Pharmaceutical Company

AstraZeneca

Eli Lilly and Company

H. Lundbeck A/S

Servier

LivaNova

Johnson and Johnson

Technische Universität Dresden

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

https://link.springer.com/content/pdf/10.1007/s40263-021-00837-6.pdf

Reference28 articles.

1. Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21:10.

2. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17.

3. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351–4.

4. Wilkinson ST, Ballard ED, Ph D, Bloch MH, Mathew SJ. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry. 2018;175:150–8.

5. Price RB, Nock MK, Charney DS, Mathew SJ. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry Society of Biological Psychiatry. 2009;66:522–6.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing real-world benefit and risk of new psychedelic medications: the need for innovative postmarket surveillance;Nature Mental Health;2024-05-03

2. Comparison of esketamine and remifentanil in combination with propofol in patients with septic shock receiving invasive mechanical ventilation: a randomized controlled trial;2024-03-21

3. Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada;Frontiers in Psychiatry;2024-01-08

4. Psychopharmakotherapie mit dem MAO-Hemmer Tranylcypromin Schwerpunkte und Trends aus Theorie und Praxis;Fortschritte der Neurologie · Psychiatrie;2023-11-21

5. Comparison of remifentanil and esketamine in combination with propofol for patient sedation during fiberoptic bronchoscopy;BMC Pulmonary Medicine;2023-07-11